Skip to main content
. 2013 Feb 7;15(5):595–606. doi: 10.1093/neuonc/nos331

Table 3.

Univariate analyses

Parameter n = 386 Overall survival since histological diagnosis
Median (months) P value Hazard ratio 95% CI
Tumor volume .002
 <100cc 335 249 1 (ref)
 ≥100cc 51 142 2.31 1.27–3.96
Spontaneous VDE <.001
 <8 mm/year 320 249 1 (ref)
 ≥8 mm/year 66 91 3.96 2.25–6.66
Spontaneous VDE <.001
 <4 mm/year 196 253 1 (ref)
 4 and <8 mm/year 126 210 1.33 0.59–1.50
 8 and <12 mm/year 26 91 3.41 1.19–4.99
 12 and >mm/year 40 75 5.91 2.28–8.82
First-line surgical resection .054
 No 196 210 1 (ref)
 Yes 190 249 0.74 0.47–1.15
Parameter n = 380 Malignant free survival since histological diagnosis
Corpus callosum involvement .003
 No 330 95 1 (ref)
 Yes 50 59 1.73 1.16–2.50
Contrast enhancement .014
 No 317 93 1 (ref)
 Faint and patchy 51 89 1.46 1.11–1.88
 Nodular-like 12 39 2.19 1.22–3.72
Tumor volume .001
 <100cc 330 93 1 (ref)
 ≥100cc 50 48 1.90 1.26–2.76
Spontaneous VDE <.001
 <8 mm/year 316 103 1 (ref)
 ≥8 mm/year 64 39 3.50 2.44–4.94
Spontaneous VDE <.001
 <4 mm/year 195 117 1 (ref)
 4 and <8 mm/year 123 83 1.43 0.78–1.91
 8 and <12 mm/year 25 60 2.71 1.15–3.16
 12 and >mm/year 39 31 6.50 3.23–7.92
First-line surgical resection <.001
 No 192 68 1 (ref)
 Yes 188 127 0.42 0.31–0.57
Extent of surgical resection <.001
 Biopsy 192 68 1 (ref)
 Partial removal 86 103 0.59 0.22–0.96
 Subtotal removal 64 133 0.39 0.14–0.78
 Total removal 38 . 0.09 0.003–0.17